NextCell Pharma 配当金
配当金 基準チェック /06
NextCell Pharma does not have a record of paying a dividend.
主要情報
n/a
配当利回り
-31.3%
バイバック利回り
| 総株主利回り | -31.3% |
| 将来の配当利回り | n/a |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | n/a |
最近の配当金アップデート
更新なし
Recent updates
We Think NextCell Pharma (STO:NXTCL) Needs To Drive Business Growth Carefully
Mar 09
We're Not Very Worried About NextCell Pharma's (STO:NXTCL) Cash Burn Rate
Oct 07NextCell Pharma (STO:NXTCL) Is In A Good Position To Deliver On Growth Plans
May 23NextCell Pharma (STO:NXTCL) Is In A Good Position To Deliver On Growth Plans
Feb 01We Think NextCell Pharma (STO:NXTCL) Can Afford To Drive Business Growth
Sep 21Here's Why We're Not Too Worried About NextCell Pharma's (STO:NXTCL) Cash Burn Situation
May 31We Think NextCell Pharma (STO:NXTCL) Needs To Drive Business Growth Carefully
Feb 15決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if NXTCL's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if NXTCL's dividend payments have been increasing.
配当利回り対市場
| NextCell Pharma 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (NXTCL) | n/a |
| 市場下位25% (SE) | 1.6% |
| 市場トップ25% (SE) | 4.5% |
| 業界平均 (Biotechs) | 1.5% |
| アナリスト予想 (NXTCL) (最長3年) | n/a |
注目すべき配当: Unable to evaluate NXTCL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate NXTCL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate NXTCL's payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as NXTCL has not reported any payouts.